Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Dallas-Fort Worth-Arlington, TX MSA — September 2026
DFW regulatory and data talent defies metro's softening labor market.
DFW unemployment climbed to 4.4% in August, yet Regulatory Affairs Specialist pay rose significantly to $107,217 and Clinical Data Manager pay hit $122,953 even as the national figure for that role declined.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- DFW unemployment rate: 4.4% — Up from 4.1% in February 2026
- DFW average weekly wage: $1,785 — vs $1,654 U.S. average, Q1 2026
- Texas life sciences employment: 129,245 workers — 21.6% growth since 2019, 9,212 establishments
- New Houston biomanufacturing investment: $8.8B combined — Lilly ($6.5B) + BMS ($2.3B), Generation Park
Key takeaways
Regulatory Affairs pay is outrunning the national trend.
Metro median advertised pay for Regulatory Affairs Specialists sits at $107,217, up significantly, versus a flat national figure near $104,000. Local scarcity appears to be driving compensation above typical geographic discount expectations for Dallas, a signal worth testing against current offer structures.
Clinical Data Manager pay diverges sharply from national direction.
Metro median rose significantly to $122,953 while the national median declined moderately to $123,031 — a reversal that may suggest DFW employers are competing harder for data management talent even as national demand softens. Treat this as a local anomaly worth monitoring rather than assuming convergence with national trend lines.
CRA pay gap with national market remains wide despite local gains.
Metro median for Clinical Research Associates moved up moderately to $65,000, but still trails the national median of $90,956 by a significant margin. Clinical ops roles may remain a stronger candidate for CRO partnership than in-house hiring in this market, particularly given state-level skew toward regional operations rather than headquarters functions.
Houston manufacturing investment is a DFW talent story too.
Eli Lilly's and Bristol Myers Squibb's combined $8.8B in new Houston-area manufacturing capacity creates statewide competition for quality and process talent, not just a regional one. Validation Engineer pay in DFW is already up significantly to $96,858, consistent with early spillover pressure on quality-adjacent roles.
Median advertised pay by role — Dallas-Fort Worth-Arlington, TX MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $78,366 | $123,070 | $125,335 | Significant increase | $131,354 |
| Clinical Research Associate | $57,103 | $65,000 | $70,113 | Moderate increase | $90,956 |
| Lab Technician | $38,796 | $47,840 | $51,604 | Stable | $47,402 |
| Regulatory Affairs Specialist | $73,465 | $107,217 | $116,091 | Significant increase | $104,000 |
| Clinical Data Manager | $100,190 | $122,953 | $122,953 | Significant increase | $123,031 |
| Biostatistician | $82,886 | $83,465 | $90,989 | Significant increase | $133,322 |
| Validation Engineer | $73,478 | $96,858 | $105,780 | Significant increase | $108,377 |
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
DFW unemployment climbed to 4.4% in August against a backdrop of 54,000 jobs added over the year, but Information sector losses of 2.8% signal selective softening even as Professional and Business Services and Education/Health Services sectors continue expanding. Eli Lilly's $6.5B Houston facility and Bristol Myers Squibb's $2.3B Generation Park investment are pulling biomanufacturing talent statewide, tightening the specific credential pools DFW life sciences employers compete for even as headline unemployment rises.
What it means
Metro-wide labor softening does not extend to life sciences specialty talent — advertised pay for Regulatory Affairs Specialists ($107,217 metro median, up significantly) and Research Scientists ($123,070, up significantly) is accelerating even as broader DFW wage growth trails the national rate. Statewide manufacturing capacity expansion in Houston reduces the case for assuming CDMO outsourcing is reliably cheaper than regional insourcing, since the same skilled operator and quality-specialist pools are now contested across Texas metros. Consider reviewing build-vs-outsource manufacturing assumptions against current in-state capacity competition rather than historical cost comparisons.
Looking ahead
Worth watching: DFW unemployment has risen from 4.1% in February to 4.4% in August — watch whether this normalization reaches specialized scientific and regulatory roles or stays concentrated in Information and general metro employment.
Emerging pressure point: San Jacinto College's NIBRT-licensed biotechnology training center opened in the region as the only one of its kind in the southern U.S. Watch whether graduate output begins easing Lab Technician and entry-level manufacturing talent constraints over the next two cohorts.
Potential inflection point: Houston's $8.8B in new biomanufacturing capacity (Lilly, BMS) may begin drawing experienced quality and process talent away from DFW employers as hiring ramps. Monitor whether Validation Engineer and CMC-adjacent postings show accelerating wage pressure as a leading indicator.
Early indicator: National biopharma WARN activity concentrated in consolidation-driven roles (BioMarin, Bristol Myers) rather than execution functions. Track whether any displaced regulatory or clinical talent surfaces in the DFW candidate pool, which could temporarily ease the current scarcity in those specific functions.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.
